title: Melatonin inhibits granulocyte adhesion to ICAM via MT3/QR2 and MT2 receptors.
abstract: Neutrophils are cells of the innate immune system that first respond and arrive to the site of infection. Melatonin modulates acute inflammatory responses by interfering with leukocyte recruitment. It is known that melatonin modulates granulocyte migration though the endothelial layer thereby acting on the endothelial cell. Here we investigated whether melatonin could modulate granulocyte infiltration by acting directly on granulocytes. Granulocyte infiltration into the peritoneal cavity was investigated in mice kept at normal light/dark conditions and mice kept under constant lighting. To induce migration of neutrophils from the blood into the injury site via the endothelial layer, a bacterial product N-formyl-l-methionyl- l-leucyl- l-phenylalanine (fMLP) was injected into the peritoneal cavity. We found that the number of infiltrated granulocytes during the dark time was lower than that during the light time. It did not depend on circadian time. Moreover, the expression of an adhesion molecule, CD18, on granulocytes, was also lower during the dark time as compared with the light time. We have found that melatonin inhibited fMLP-induced CD18 up-regulation. Importantly, melatonin also inhibited the integrin-mediated granulocyte adhesion to intercellular adhesion molecule-coated plates. This study additionally showed that melatonin receptors MT2 and MT3/quinone reductase 2 (QR2) are expressed on granulocytes. Interestingly, melatonin increases the expression of its MT3/QR2 receptor. The fMLP-mediated CD18 up-regulation was inhibited by melatonin via MT2 receptor and the integrin-mediated granulocyte adhesion was inhibited by melatonin via MT3/QR2 and MT2 receptors. In conclusion, we show that melatonin suppresses granulocyte migration via endothelium by acting directly on granulocytes.
authors.affiliation: Department of Immunology, State Research Institute Centre for Innovative Medicine, LT-08409 Vilnius, Lithuania.
authors.forename: Vitalij
authors.initials: V
authors.lastname: Černyšiov
authors.affiliation: Department of Immunology, State Research Institute Centre for Innovative Medicine, LT-08409 Vilnius, Lithuania.
authors.forename: Mykolas
authors.initials: M
authors.lastname: Mauricas
authors.affiliation: Department of Immunology, State Research Institute Centre for Innovative Medicine, LT-08409 Vilnius, Lithuania igirkontaite@yahoo.com.
authors.forename: Irute
authors.initials: I
authors.lastname: Girkontaite
mesh_terms: D000221:Adaptation, Ocular; D000818:Animals; D018821:CD18 Antigens / Q000235:genetics / Q000378:metabolism; D002448:Cell Adhesion / Q000187:drug effects; D002465:Cell Movement / Q000187:drug effects; D002478:Cells, Cultured; D006098:Granulocytes / Q000187:drug effects / Q000276:immunology*; D018799:Intercellular Adhesion Molecule-1 / Q000378:metabolism*; D008550:Melatonin / Q000008:administration & dosage / Q000378:metabolism*; D000090023:Metallothionein 3; D051379:Mice; D008807:Mice, Inbred BALB C; D009240:N-Formylmethionine Leucyl-Phenylalanine / Q000008:administration & dosage; D010529:Peritoneal Cavity / Q000166:cytology*; D044123:Receptor, Melatonin, MT2 / Q000378:metabolism*; D015854:Up-Regulation / Q000187:drug effects
chemical_list: D018821:CD18 Antigens; D000090023:Metallothionein 3; C000715430:Mt3 protein, mouse; D044123:Receptor, Melatonin, MT2; D018799:Intercellular Adhesion Molecule-1; D009240:N-Formylmethionine Leucyl-Phenylalanine; D008550:Melatonin
keywords: MT2; MT3/QR2; adhesion; granulocytes; melatonin; neutrophils